2ozr
From Proteopedia
Line 4: | Line 4: | ||
|PDB= 2ozr |SIZE=350|CAPTION= <scene name='initialview01'>2ozr</scene>, resolution 2.300Å | |PDB= 2ozr |SIZE=350|CAPTION= <scene name='initialview01'>2ozr</scene>, resolution 2.300Å | ||
|SITE= | |SITE= | ||
- | |LIGAND= | + | |LIGAND= <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=GG1:4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC+ACID'>GG1</scene>, <scene name='pdbligand=HAE:ACETOHYDROXAMIC+ACID'>HAE</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> |
|ACTIVITY= | |ACTIVITY= | ||
|GENE= MMP13 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | |GENE= MMP13 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | ||
+ | |DOMAIN= | ||
+ | |RELATEDENTRY=[[2ow9|2OW9]] | ||
+ | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2ozr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2ozr OCA], [http://www.ebi.ac.uk/pdbsum/2ozr PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2ozr RCSB]</span> | ||
}} | }} | ||
Line 43: | Line 46: | ||
[[Category: Wilson, M.]] | [[Category: Wilson, M.]] | ||
[[Category: Yan, C H.]] | [[Category: Yan, C H.]] | ||
- | [[Category: CA]] | ||
- | [[Category: GG1]] | ||
- | [[Category: HAE]] | ||
- | [[Category: ZN]] | ||
[[Category: crystal complex structure]] | [[Category: crystal complex structure]] | ||
[[Category: hydrolase]] | [[Category: hydrolase]] | ||
Line 53: | Line 52: | ||
[[Category: mmp13 specific inhibitor]] | [[Category: mmp13 specific inhibitor]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 04:25:38 2008'' |
Revision as of 01:25, 31 March 2008
| |||||||
, resolution 2.300Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , , , | ||||||
Gene: | MMP13 (Homo sapiens) | ||||||
Related: | 2OW9
| ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid
Overview
Matrix metalloproteinase-13 (MMP13) is a Zn(2+)-dependent protease that catalyzes the cleavage of type II collagen, the main structural protein in articular cartilage. Excess MMP13 activity causes cartilage degradation in osteoarthritis, making this protease an attractive therapeutic target. However, clinically tested MMP inhibitors have been associated with a painful, joint-stiffening musculoskeletal side effect that may be due to their lack of selectivity. In our efforts to develop a disease-modifying osteoarthritis drug, we have discovered MMP13 inhibitors that differ greatly from previous MMP inhibitors; they do not bind to the catalytic zinc ion, they are noncompetitive with respect to substrate binding, and they show extreme selectivity for inhibiting MMP13. By structure-based drug design, we generated an orally active MMP13 inhibitor that effectively reduces cartilage damage in vivo and does not induce joint fibroplasias in a rat model of musculoskeletal syndrome side effects. Thus, highly selective inhibition of MMP13 in patients may overcome the major safety and efficacy challenges that have limited previously tested non-selective MMP inhibitors. MMP13 inhibitors such as the ones described here will help further define the role of this protease in arthritis and other diseases and may soon lead to drugs that safely halt cartilage damage in patients.
About this Structure
2OZR is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects., Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD, J Biol Chem. 2007 Sep 21;282(38):27781-91. Epub 2007 Jul 10. PMID:17623656
Page seeded by OCA on Mon Mar 31 04:25:38 2008
Categories: Homo sapiens | Single protein | Banotai, C A. | Baragi, V. | Bornemeier, D A. | Datta, K. | Dyer, R D. | Fasquelle, V. | Guzman, R. | Han, H K. | Johnson, A R. | Lesch, C. | Lie, J J. | Man, C F. | McConnell, P. | Mueller, W T. | Ortwine, D F. | Pavlovsky, A G. | Prior, F. | Roark, W H. | Robertson, D. | Wilson, M. | Yan, C H. | Crystal complex structure | Hydrolase | Matrix metalloproteinase | Mmp13 catalytic domain | Mmp13 specific inhibitor